Oncology
Research activity includes unresectable pancreatic cancer and aggressive non-Hodgkin lymphoma subtypes, with attention to DLBCL, high-grade B-cell lymphoma, and related B-cell malignancies.
- Pancreatic cancer
- Non-Hodgkin lymphoma
- DLBCL
- CAR-T cell therapy
The sponsor’s oncology portfolio spans solid tumours and haematological cancers, with a focus on treatment strategies for resistant and advanced disease.
Cardiovascular Medicine
Clinical research addresses recent myocardial infarction complicated by iron deficiency, with interest in recovery, heart failure events, and patient-reported outcomes after acute cardiac injury.
- Myocardial infarction
- Iron deficiency
- Heart failure
- Quality of life
This area reflects involvement in post-infarction care and the management of cardiovascular complications linked to disturbed iron metabolism.
Transplantation and Viral Infections
Work in this field focuses on resistant viral infections caused by cytomegalovirus in adults after allogeneic haematopoietic stem cell transplantation, with emphasis on difficult-to-control post-transplant infection.
- Cytomegalovirus
- Allogeneic haematopoietic stem cell transplantation
- Refractory viral infection
- Viral-specific T-cell therapy
The sponsor is active in transplant-related infectious disease research where immune reconstitution and viral control are central therapeutic concerns.
Infectious Diseases and Antimicrobial Carriage
Another area of interest is chronic active Staphylococcus aureus mono-infection and asymptomatic nasal carriage, including MRSA colonisation of the nasal cavity.
- Staphylococcus aureus
- MRSA
- Nasal carriage
- Microbiological eradication
These studies reflect a clinical interest in persistent bacterial colonisation and infection control in a community and hospital-related context.
